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Summary
Persistent pain induced by noxious stimuli is characterized by the transition from normosensitivity
to hypersensitivity. Underlying mechanisms are not well understood, although gene expression is
considered important. Here we show that persistent nociceptive-like activity triggers calcium
transients in neuronal nuclei within the superficial spinal dorsal horn, and that nuclear calcium is
necessary for the development of long-term inflammatory hypersensitivity. Using a nucleus-
specific calcium signal perturbation strategy in vivo complemented by gene profiling,
bioinformatics and functional analyses, we discovered a pain-associated, nuclear calcium-
regulated gene program in spinal excitatory neurons. This includes C1q, a novel modulator of
synaptic spine morphogenesis, which we found to contribute to activity-dependent spine
remodelling on spinal neurons in a manner functionally associated with inflammatory
hypersensitivity. Thus, nuclear calcium integrates synapse-to-nucleus communication following
noxious stimulation and controls a spinal genomic response that mediates the transition between
acute and long-term nociceptive sensitization by modulating functional and structural plasticity.
© 2012 Elsevier Inc. All rights reserved.
*Correspondence should be addressed to H.B. at Hilmar.Bading@uni-hd.de or to R. K. at rohini.kuner@pharma.uni-heidelberg.de.ΨThese authors contributed equally to the study.
ACCESSION NUMBERS
Complete profiling data have been uploaded in the public domain with the accession number E-MTAB-1416.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Neuron. Author manuscript; available in PMC 2014 January 09.
Published in final edited form as:
Neuron. 2013 January 9; 77(1): 43–57. doi:10.1016/j.neuron.2012.10.037.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Introduction
Peripheral and central neural networks mediating the complex experience of pain show
various forms of plasticity in pathological disease states over diverse temporal and
anatomical scales, leading to exaggerated responses to noxious stimuli (hyperalgesia) and
may contribute to aberrant pain sensation in response to non-noxious sensory inputs
(allodynia) (Kuner, 2010; Sandkühler, 2009). Despite recent advances, the molecular basis
of transition between acute sensitization and long-term hypersensitivity is not well
understood. Tremendous potential for long-term plasticity lies in the ability of synaptic
nociceptive mediators and cellular modulators to trigger changes in gene expression (Woolf
and Costigan, 1999). Addressing how local synaptic events are spatio-temporally linked to
the modulation of gene expression in pain networks is therefore important for understanding
sensitization mechanisms.
Recent studies have revealed important insights into routes for synapse-to-nucleus
communication in the context of neuronal survival and long-term memory (Hagenston and
Bading, 2011). Calcium signals couple synaptic activity to the regulation of gene
transcription and thus serve as mediators of the dialogue between synapses and the nucleus
(Hardingham et al., 2001; Bengtson et al., 2010). Nuclear calcium acting primarily via
nuclear calcium/calmodulin-dependent (CaM) protein kinases II and IV regulates genomic
programs, that have been studied in the context of neuronal survival, synaptic plasticity and
memory formation, particularly in hippocampal neurons (Limbäck-Stokin et al., 2004;
Zhang et al., 2007, 2009; Mauceri et al., 2011; Oliveira et al., 2012). The cyclic AMP
response element binding protein (CREB), a major target of nuclear calcium-CaMKIV
signaling (Hardingham et al., 1997; Hardingham et al., 2001), can bind to and influence the
activity of 4000 to 6000 promoter sites in the rat or human genomes (Impey et al., 2004).
Nuclear calcium-CaMKIV signaling also regulates the activity of the transcriptional co-
activator CREB binding protein (CBP) (Hagenston and Bading, 2011) that interacts with
CREB but also with a number of other DNA binding proteins (Vo and Goodman, 2001).
Furthermore, nuclear calcium also initiates genome wide modifications of the chromatin
state in response to synaptic activity, e.g. via CaMKII-mediated phosphorylation of Methyl-
CpG-binding Protein 2 (MeCP2) on its activator site serine 421 (Buchthal et al., 2012) or
transcriptional induction of the de novo DNA methyltransferase, Dnmt3a2 (Oliveira et al.,
2012).
Previous studies have reported roles for many transcriptional regulators including CREB and
MeCP2 in nociceptive plasticity (Fang et al., 2002; Ji et al., 1999; Geranton et al., 2007).
However, little is known about the potential for nociceptive activity to trigger nuclear
calcium signaling and it remains unknown whether nuclear calcium serves as a signaling end
point in pain-associated synapse-to-nucleus communication.
Here we show that persistent nociceptive-like activity triggers calcium transients in the
nuclei of spinal dorsal horn neurons, which play a key role in the development of persistent
inflammatory pain, but not in the basal pain sensitivity or the acute sensitization evoked by
nociceptive inputs. A genome-wide transcriptome analysis uncovered a distinct spinal gene
pool directly regulated by nuclear calcium that not only includes a large set of known, key
pain-related genes, but also novel plasticity-related genes and regulators of spinal dendritic
spine remodeling. Thus, functional and structural plasticity governed by a nuclear calcium-
driven genomic response is a key intermediate step linking nociceptive activity and the
development of long-lasting hypersensitivity.
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Results
Viral-mediated delivery of tools for analyzing nuclear calcium signaling in the mouse
spinal cord in vivo
We used recombinant adeno-associated virus (rAAV)-mediated gene delivery (During et al.,
2003) to overexpress molecular tools for either imaging or quenching nuclear calcium
signals. Our objective was to specifically target excitatory neurons in the superficial spinal
laminae that receive and process nociceptive information from peripheral sensory afferents
and then subsequently project this information to the brain. Nuclear calcium signaling was
blocked by means of expression of Calmodulin binding protein 4 (CaMBP4), a nuclear
protein that contains 4 repeats of the M13 calmodulin-binding peptide derived from the
rabbit skeletal muscle myosin light chain kinase, which has been characterized previously
(Wang et al., 1995 Zhang et al., 2007; Zhang et al., 2009, Mauceri et al. 2011). CaMBP4
does not buffer calcium, but instead binds calcium-bound calmodulin and prevents the
activation of downstream signaling cascades. It’s effects on synaptic activity-dependent
transcription that is associated with acquired neuroprotection and memory formation has
been characterized previously both in vitro and in vivo (Mauceri et al., 2011; Limbäck-
Stokin et al., 2004; Zhang et al., 2007; Zhang et al., 2009). The rAAV vectors used contain
an expression cassette that harbors a promoter fragment derived from the CaMKIIα
promoter and drive expression of mCherry (rAAV-mCherry) or mCherry fused to either
CaMBP4 (rAAV-CaMBP4) (Fig. 1A) or to the inactive CaMBP4 mutant, CaMBP4mu
(rAAV-CaMBP4mu). To preferentially infect neurons, the neurotropic chimaeric serotype
1/2 was used (During et al., 2003).
We have previously demonstrated that stereotaxic injection of rAAVs (serotype 1/2) directly
into the spinal parenchyma enables stable and long-lasting gene delivery with a high rate of
gene transduction without inducing any signs of persistent inflammation, injury, gliosis or
scar formation (Tappe-Theodor et al., 2007). By mapping the cellular expression patterns of
mCherry-tagged CaMBP4 (CaMBP4-mCherry) and mCherry as the prototypes for the
different virally expressed proteins used in this study, we found that viral-mediated
expression was largely limited to the spinal dorsal horn and, owing to the incorporation of a
nuclear localization signal in the expression constructs, was restricted to cell nuclei
(Supplementary Fig. 1A).
Co-immunostaining for the neuronal marker NeuN demonstrated a more than 90% co-
localization with mCherry or mCherry-tagged CaMBP4 in the superficial spinal laminae
(Fig 1B and supplementary Fig. 1B; quantification in Fig. 1C), but not with GFAP, an
astrocytic marker or with Iba1, a microglial marker (Fig 1B and supplementary Fig 1B).
Using indicator mice that express EGFP in the cell bodies of either glycinergic inhibitory
neurons (GlyT2-EGFP) or GABAergic inhibitory interneurons (GAD67-EGFP), we
observed that only a small proportion (6–7%) of inhibitory glycinergic or GABAergic
interneurons expressed CaMBP4 or mCherry in the spinal dorsal horn (typical examples in
Fig. 1D; quantitative analysis in Fig. 1E). Expression in the spinal dorsal horn was evident
throughout the spinal segments L2-S1, but reached its maximum in L3–L5, which innervate
the hindpaw (supplementary Fig. 1C).
Nociceptive-like synaptic activity induces calcium transients in neuronal nuclei of the
spinal dorsal horn
Although it has been suggested that synaptic activity-induced calcium signals can be
transduced to the cell soma and invade the cell nucleus, for example in hippocampal neurons
(Hardingham, et al. 2001), only recently has it become possible to unambiguously detect
calcium transients in the nuclear compartment using genetically-encoded calcium indicators
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targeted specifically to cell nuclei (Bengtson, et al. 2010). We used rAAVs to express the
calcium sensors GCaMP2.NLS (Bengtson, et al. 2010) or TnXXL.NLS, which are targeted
to the nucleus via a tripartite nuclear localization signal at their C-termini, in excitatory
neurons of the L3–L5 lumbar spinal cord (Fig. 1F). In acute transverse slices from mice
injected with rAAV-GCaMP2.NLS (Supplementary Fig. 2A), electrical stimulation of dorsal
roots through a suction electrode (20–100 Hz, 0.4–2.0 mA) induced fluorescence intensity
changes (Fig. 1G), which corresponded with nuclear calcium transients with a steep rise and
slower decay, and that returned to near baseline values within 10 s of stimulus conclusion
(traces in Fig 1H). The amplitudes of evoked nuclear calcium transients varied positively
with both stimulus intensity (0.4–2.0 mA) (Fig. 1I, J) and frequency (20–100 Hz) (for
example, transients at 0.8 mA stimulation intensity are shown in Fig. 1K). These data
indicate that robust nuclear calcium responses in nociceptive spinal neurons can be evoked
through repetitive stimulation – an activity pattern that may accompany a persistent
nociceptive stimulus following injury - as well as by the recruitment of nociceptive C-fiber
afferents, which occurs predominantly at higher stimulation intensities (Torsney and
MacDermott 2006).
Similar results were obtained when we employed a nuclearly targeted FRET-based calcium
indicator, TnXXL.NLS, which by virtue of being a ratiometric, is expected to deliver more
consistent responses across experimental preparations independently of expression levels.
The amplitudes of evoked nuclear calcium transients (supplementary Fig. 2D) varied
positively with both stimulus intensity (supplementary Fig. 2E, F) and frequency
(supplementary Fig. 2G). When imaging was performed 24h after bilateral plantar injection
of complete Freund’s adjuvant (CFA) or PBS (control), we found no detectable differences
in the amplitudes of nuclear calcium transients in spinal neurons between CFA-treated and
PBS-treated animals, regardless of the stimulation intensity (0.2–3.0 mA) or frequency (1–
100 Hz) used (supplementary Fig. 2E–G).
Impact of the blockade of nuclear calcium signaling on behavioral correlates of
nociception and inflammatory pain
Using a dynamic aesthesiometer to measure mechanical sensitivity and a plantar test device
to study responses to sensitivity to infrared heat, we observed that basal pain sensitivity was
similar in mice expressing CaMBP4-mCherry (hereafter referred to simply as CaMBP4) or
mCherry (control) in the spinal dorsal horn (Fig. 2A and 2B). CaMBP4 expression did,
however, significantly impair the development of mechanical and thermal hypersensitivity
following the induction of unilateral hind paw inflammation with CFA. Following CFA-
induced inflammation, mCherry-expressing mice showed markedly reduced response
latencies to thermal stimulation compared to baseline (black circles in Fig. 2C; P < 0.05,
ANOVA). This thermal hypersensitivity lasted for up to 7 days following CFA injection. In
contrast, CFA-induced inflammation did not significantly alter thermal latency in rAAV-
CaMBP4-injected animals (red squares in Fig. 2C). Similarly, the development of
mechanical hypersensitivity, evident as a decrease in the mechanical response threshold over
baseline, occurred prominently in rAAV-mCherry-injected mice, but only to a minor extent
in rAAV-CaMBP4-injected animals (Fig. 2D) throughout the time course of CFA-induced
inflammation (up to 10 d; P < 0.05, ANOVA). In these experiments, graded von Frey hairs
(0.07 – 4g) were applied to the plantar surface and withdrawal threshold was determined as
the von Frey filament at which the animal withdrew its paw at least three times out of 8
applications, normalizing basal (pre-CFA) values to 100%. The drop in withdrawal
threshold was significantly less pronounced in mice expressing CaMBP4 as compared to
mice expressing mCherry (Fig. 2D). To comprehensively present all data on response
frequencies to graded von Frey hairs over all forces tested, we constructed a response
frequency vs. stimulus intensity (i.e. von Frey force applied) curve per group for every time
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point tested and calculated Area under curve (AUC), which was markedly lower in
CaMBP4-expressing mice than in mCherry-expressing mice (Fig. 2E). Importantly, mice
expressing an inactive mutant of CaMBP4 (CaMBP4mu) exhibited normal levels of thermal
and mechanical hyperalgesia (Fig. 2C–E), indicating that the altered nociceptive sensitivity
in CaMBP4-expressing mice can be attributed to the functional properties of CaMBP4.
Role of a nuclear calcium effector, CaMKIV, in spinal nociceptive sensitization
Amongst the various signaling events triggered by nuclear calcium/calmodulin, CaMKIV, is
particularly importance for gene regulation (Kotera et al., 2005; Racioppi and Means, 2008).
To address whether CaMKIV signaling contributes to the observed phenotypic profile of
nuclear calcium signaling manipulation, we used a kinase-dead, dominant-negative mutant
version of CaMKIV (CaMKIVK75E (Anderson et al., 1997; Mauceri et al., 2011; Zhang et
al., 2009). Following rAAV-mediated spinal expression of a FLAG-tagged version of
CaMKIVK75E, anti-FLAG immunoreactivity revealed the typical, primarily cytosolic
localization of CaMKIVK75E (Chow et al., 2005) over the entire neuronal soma and the
neuropil of superficial spinal dorsal horn neurons (Fig. 2F; higher magnification in right
hand panel). Following CFA-induced paw inflammation, mice injected into the spinal cord
with rAAV-CaMKIVK75E initially developed mechanical hypersensitivity to a similar
extent as rAAV-mCherry-injected mice (Fig. 2G, H), but significantly less mechanical
hypersensitivity than the mCherry-expressing group starting from 3 d after injection and,
unlike rAAV-mCherry-injected mice, recovered baseline mechanical sensitivity within 5 d
after injection (Fig. 2G, H). In contrast, CFA-induced thermal hypersensitivity was not
markedly affected in rAAV-CaMKIV75E-injected mice (Fig. 2I), indicating that particularly
the late phase of nuclear calcium-induced mechanical hypersensitivity, but not thermal
hypersensitivity, is mediated by activation of CaMKIV in excitatory neurons of the spinal
dorsal horn.
Interference with nuclear calcium signaling abrogates nociceptive activity-dependent
activation of CREB despite intact ERK1/2 activation
At 24h following CFA-induced peripheral inflammation, serine 133-phosphorylated form of
CREB (pCREB) showed increased immunoreactivity in the somata over the entire spinal
dorsal horn in rAAV-mCherry-injected animals (Fig. 3A) as well as increased expression in
immunoblot analyses using lysates of bilaterally-isolated spinal dorsal horns following
bilateral intraplantar injection of CFA (Fig. 3B; quantitative analysis from at least 3
experiments in Fig. 3B right panel). In contrast, in mice expressing CaMBP4, paw
inflammation failed to increase pCREB immunoreactivity and pCREB expression levels in
the spinal dorsal horn (Fig. 3A–B) without any change in basal levels of pCREB
immunoreactivity or expression levels of CREB protein in the spinal cord (Fig. 3A–B).
In contrast, after CFA-induced paw inflammation, increased immunoreactivity for the
activated, i.e., phosphorylated, forms of ERK1 and ERK2 (pERK1/2) was observed in the
neuropil of the superficial spinal dorsal horn in rAAV-mCherry-injected mice as well as in
rAAV-CaMBP4-injected mice (Fig. 3C), which was further confirmed by immunoblot
analysis (Fig. 3D). These results indicate an absence of compensatory changes in parallel
modes of synapse-to-nucleus communication following specific perturbation of nuclear
calcium signaling in the spinal dorsal horn.
Upon induction of paw inflammation, IEGs, such as c-fos and egr1 as well as critical
effector genes of nuclear calcium signaling, such as camk2a and (Ptgs2) (encoding Cox-2),
were found to undergo a biphasic transcriptional response with a rapid and transients
induction within the first 1 to 6 h after stimulation, followed by a delayed increase in
expression at 24 h (Fig. 3E, F), which matched the functional outcomes (i.e. behavioral
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hypersensitivity and structural plasticity) that we analyzed 24 h after induction of
nociceptive activity (see below).
Differential regulation of acute or chronic plasticity processes regulated by nuclear
calcium signals in the spinal cord
We next investigated the temporal phases over which nuclear calcium-driven plasticity
processes are operational. We observed that intraplantar injection of capsaicin in the paw
acutely evoked nocifensive behaviors, which range between tens of seconds to a few
minutes, to a similar extent in rAAV-CaMBP4-injected and rAAV-mCherry-injected mice
(Fig. 4A). Furthermore, intraplantar formalin- induced acute nociceptive behaviors (phase 1,
0–10 min post-injection) and the development of acute nociceptive hypersensitivity, which
is known to depend on plasticity in the central nervous system as well as on-going
nociceptor activation (phase 2, 15–60 min) were comparable over rAAV-CaMBP4-injected
and rAAV-mCherry-injected mice (Fig. 4B).
The mouse knee arthritis model, which involves unilateral knee-injection of kaolin and
carrageenan, enables the assessment of secondary hyperalgesia at hindpaws ipsilateral and
contralateral to the inflamed knee (i.e., distinct dermatomes and contralateral processing)
and thereby provides insights into central (spinal) mechanisms of nociceptive plasticity
spanning several weeks. Whereas rAAV-mCherry-injected mice showed ipsilateral
hypersensitivity lasting several weeks and beginning within a few days after induction of
knee arthritis, rAAV-CaMBP4-injected mice failed to develop hyperalgesia over the entire
temporal course of arthritic pain assessment (Fig. 4C, 4D). Similar results were obtained for
the contralateral paw hyperalgesia after knee arthritis (Supplementary Fig. 3A, B). These
behavioral differences did not result from variations in the magnitude of inflammation, since
knee edema as well as infiltration of GR1-immunoreactive macrophages into the synovial
membrane (Gangadharan et al., 2011) were comparable in rAAV-mCherry-injected and
rAAV-CaMBP4-injected mice (Supplementary Fig. 3C, 3D). Taken together, the results
obtained from the capsaicin, formalin, paw inflammation and knee arthritis models suggest
that nuclear signaling-dependent plasticity processes do not become evident until several
hours after intense nociceptive activity, and that they can persist for several weeks.
Phase-dependent blockade of inflammatory pain by spinal CaMBP4
To determine the contribution of nuclear calcium signaling to the maintenance of
inflammatory hypersensitivity independently of the induction phase, we induced arthritic
pain prior to expression of CaMBP4. Following development of mechanical hypersensitivity
36 h after arthritis induction (Fig. 4E), mice were randomly divided into two groups,
receiving spinal injection of rAAV-mCherry or rAAV-CaMBP4. In a pilot experiment, we
ascertained that injecting rAAVs in the spinal dorsal horn did not, by itself, affect arthritic
hypersensitivity at 2–3 days after surgery. Corresponding to the time course of viral
expression (i.e. starting 7 days), rAAV-CaMBP4-injected mice showed significantly less
mechanical hypersensitivity than did rAAV-mCherry-injected mice starting from day 15
onwards after injection (P < 0.05, ANOVA) (summary of sensitivity over all mechanical
forces is shown in Fig. 4E and responses to a force of 0.07 g shown in Fig. 4F). Despite this
difference, CaMBP4-expressing mice exhibited levels of mechanical sensitivity that were
significantly greater than baseline with a temporal course similar to that observed in rAAV-
mCherry-injected mice (Fig. 4E, 4F); the partial reduction is likely attributed to spinal
plasticity downstream of on-going afferent input coming in from the arthritic knee. These
results suggest that spinal nuclear calcium signaling plays a more decisive role in the
induction phase than it does in the maintenance phase of nociceptive hypersensitivity.
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Profiling genes regulated by nuclear calcium signaling in spinal neurons during
inflammatory pain
A genome-wide gene profiling in the CFA model of inflammatory pain was used to identify
genes regulated by persistent nociceptive activity in spinal neurons, and to identify the gene
pool that is specifically regulated by nuclear calcium signaling. cDNA prepared from spinal
dorsal horn tissue 24 h after bilateral intraplantar paw injection of CFA (inflamed) in rAAV-
mCherry or rAAV-CaMBP4-injected mice was used for microarray-based transcriptome
analysis, and the degree of induction or repression over basal state (control) was analyzed.
We found 3165 genes to be up-regulated and 5143 genes to be down-regulated with a P
value ≤ 0.050 in inflamed versus control samples derived from rAAV-mCherry-injected
mice (t-tests with Benjamini-Hochberg correction for multiple comparisons). To narrow
down the gene pool for subsequent detailed analyses, we set a cut-off of 1.40-fold for up-
regulated genes and of 0.70-fold for down-regulated genes in mCherry-expressing mice and
assessed how CaMBP4 expression influenced the inflammation-induced up-regulation or
down-regulation of each of these selected genes (Fig. 5A–D). All genes regulated in nuclear
calcium-dependent manner by the criteria used (see methods) are listed in Supplementary
Table 1. The complete profiling data is shown in Supplementary Table 2. Individual up-
regulated or down-regulated genes are schematically represented at the same position in
Figure 5 (panels A, B and C, D). Of the 202 genes up-regulated at least 1.40-fold following
CFA injection in mCherry-expressing mice, 127 genes (i.e., 63%) were not induced by CFA
by at least 1.40-fold in CaMBP4-expressing mice (Supplementary Table 1); these genes
were categorized as ‘100% inhibition of induction by CaMBP4’ (see methods for details)
and marked as dark blue fields in Fig. 5B (detailed information on % difference in fold-
induction is provided in Supplementary Table 2). The induction of 26 genes was inhibited
by at least 20% and that of many more genes was inhibited by between 10 and 20%
(indicated by fields in graded shades of blue in Fig. 5B). Of the 288 genes repressed by CFA
by at least 0.70-fold in mCherry-expressing mice, 164 genes (i.e., 57%) were not repressed
by at least 0.7-fold by peripheral inflammation in CaMBP4-expressing mice (Supplementary
Table 1); they were categorized as ‘100% inhibition of repression by CaMBP4’ (see
methods for details) and marked as dark blue fields in Fig. 6D (detailed information on %
difference in fold-repression is provided in Supplementary Table 2). The down-regulation of
another 34 genes was inhibited by at least 20% (blue shaded fields in Fig. 5D)
(Supplementary table 1). A small number of genes that was repressed or induced by paw
inflammation in rAAV-mCherry-injected mice was found to be repressed or induced to a
greater extent in rAAV-CaMBP4-injected mice (6.6% and 5% respectively), suggesting that
nuclear calcium signaling serves to counteract an endogenous mechanism involved in the
repression of these genes by paw inflammation (yellow and brown-shaded fields Fig. 5D)
(Supplementary Table 1). About 28% of all genes regulated within the above-mentioned cut-
off in a nuclear calcium-dependent manner in the spinal dorsal horn represent known or
putative targets of CREB as predicted by the CREB Target Gene Database (Salk Institute).
Importantly, we also observed that the regulation of a subset of genes by paw inflammation
was not significantly affected by the blockade of nuclear calcium signaling: about 10% of
genes up-regulated by at least 1.4-fold and 19% of genes down-regulated by at least 0.7-fold
in mCherry-expressing mice exhibited similar levels of regulation by paw inflammation in
CaMBP4-expressing mice (white fields in Fig. 5B and 5D, respectively).
The validity of the transcriptome data was confirmed by quantitative reverse transcriptase-
polymerase chain reaction (QRT-PCR) analysis; one example, grip1, a gene encoding the
key postsynaptic protein GRIP1 at excitatory synapses (Dong et al., 1997), is shown in Fig.
5E. As expected from previous profiling analyses (e.g. Zhang et al., 2007; Zhang et al.,
2009), the level of regulation determined by QRT-PCR analysis was much higher than that
observed in the gene chip-based assessment. Whereas CaMBP4 expression suppressed gene
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expression of some genes in both basal and inflammatory states,, e.g. the genes encoding
Tachykinin1 (Tac1) and Cholecystokinin (Cck) (Fig. 5E), expression of others was only
suppressed in inflamed mice, e.g. Gucy1α2, which encodes soluble guanylate cyclase 1
(Fig. 5E).
Nuclear calcium mediates activity-induced regulation of a large set of pain-relevant genes
Amongst the genes that were significantly regulated by paw inflammation (P < 0.05) in a
nuclear calcium-dependent manner using the criteria mentioned above, we found a large
number of genes encoding proteins that have been implicated in the positive or negative
modulation of nociception. We chose Cox-2 (Ptgs2) as an example of a prominent pain
target (Vardeh et al., 2009) and found that its regulation by nuclear calcium signaling both in
the spinal dorsal horn (Fig. 5F) and, as shown previously (Zhang et al., 2009), in
hippocampal neurons. Mice spinally injected with rAAVs to express a Cox-2 specific short
hairpin RNA (shRNA) showed lower levels of Cox-2-induction 24 h after paw inflammation
than mice expressing a control shRNA (Fig. 5F), although due to expression of Cox-2 in
glial cells (Vardeh et al., 2009) that are not targeted by the rAAV, significant amounts of
Cox-2 mRNA could still be detected in the spinal cord. The selective knock-down of Cox-2
expression in spinal excitatory neurons resulted in a failure of the animals to develop
mechanical hypersensitivity following paw inflammation (Fig. 5G), but no change in CFA-
induced thermal hypersensitivity was observed (Fig. 5H).
Interestingly, our profiling results indicate marked differences in gene programs associated
with inflammatory and neuropathic pain states. For example, genes encoding P2X4, MMP-2,
and cathepsin S, which are upregulated in neuropathic pain states (Gao and Ji, 2010) were
observed to be downregulated in spinal dorsal horn samples of inflamed mice after CFA
using QRT-PCR (Fig. 6A). Conversely, we found that genes including egr1, Ptgs2 and c-fos,
which were upregulated in inflamed mice in our profiling analyses (Fig. 3E, F & Fig. 5E),
are downregulated at 7 days after the induction of spared nerve injury (SNI), a model of
neuropathic pain (Fig. 6B). In the SNI model of neuropathic pain, mCherry- or CaMBP4-
injected mice showed a similar drop in response threshold to von Frey stimuli over basal
values (calculated as a force eliciting a miminum of 40% response frequency to 5
applications of each von Frey hair) (Fig. 6C). When stimulus intensity-response frequency
analyses were compared for all von Frey forces tested by calculating the area under the
curve (AUC), only a small, but statistically significant, decrease in the extent of SNI-
induced mechanical hypersensitivity was observed in CaMBP4-injected mice compared to
mCherry-injected mice (Fig. 6D), which can also be attributed to on-going inflammation at
the nerve injury site. This indicates differences in the requirement of nuclear calcium
signaling in spinal excitatory neurons in inflammatory and neuropathic pain processes.
Bioinformatics analysis of new genes and pathways in spinal pain processing
We subjected 421 putative targets of nuclear calcium signaling in spinal dorsal horn neurons
in inflammatory pain that were identified by the criteria used (Supplementary Table 1) to
further bioinformatics analysis of putative molecular ontology, pathways and function using
the bioCompendium database of the European Molecular Biology Laboratory (http://
biocompendium.embl.de). The best-represented functional ontologies in our group of
regulated genes corresponded to protein-binding activities, of which about a quarter show
binding to cytoskeletal elements. Amongst the genes encoding receptor molecules, the
largest fraction was represented by GPCRs, followed by tyrosine kinase receptors, cytokine
receptors, glutamate receptors, GABA-A receptors and surprisingly, receptors of the
immunoglobulin families. Finally, about 4% of the nuclear calcium target genes in the spinal
dorsal horn were kinases, in particular protein tyrosine and threonine/serine kinases,
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including members of the MAP kinase and the calcium/calmodulin-dependent kinase family,
as well as the lipid kinase, di-acyl glycerol kinase.
In a second step, we performed a network analysis using the MetaCore database (Ekins et
al., 2007) on genes chosen from profiling data. For example, a birds-eye view of the
interactions between all genes, which are up-regulated is provided in Supplementary Fig. 4.
Within these interactions, we found a number of genes to be clustered in highly connected
networks, which are indicated by an arrow in Supplementary Fig. 4A, and are shown at a
higher magnification in Supplementary Fig. 4B. Transcription factors (TFs) such as STAT-3
and STAT-1 (Supplmentary Fig. 4B) were found to serve as key nodal points in interaction
maps of the nuclear calcium-regulated gene pool, potentially implicating these TFs as key to
the cellular response to nuclear calcium signaling.
Identification of a novel nuclear calcium target and its functional validation as a modulator
of inflammatory pain
Two distinct prediction algorithms for pathway analysis (Ingenuity Systems and MetaCore;
Ekins et al., 2007) independently suggested ‘Immune response classical complement
pathway’ as the most significantly altered pathway in the spinal dorsal horn following
peripheral inflammation. In profiling analysis, we found that mCherry-expressing mice, but
not CaMBP4 expressing mice, showed a significant down-regulation of genes encoding the
complement proteins, such as the initiator of the complement cascade C1q (including all 3
members of the active complex) as well as C1, C3a, C4a, C4b and C3 convertase in the
spinal cord after paw inflammation. QRT-PCR analysis for one member of the trimeric
complex, C1q-c in CaMBP4-expressing mice, not only confirmed that nuclear calcium
signaling in spinal neurons mediates nociception-induced down-regulation of C1q, but also
indicated that it also suppresses a pathway involved in sustaining basal C1q expression
levels in the spinal neurons (Fig. 7A).
An up-regulation of complement proteins, including C1q, has been observed in spinal
microglia after nerve injury, which is consistent with our observation of C1q-c upregulation
in spinal cord of neuropathic mice (Fig. 7A), and has been associated with the activation and
proliferation of microglia in the spinal cord (Griffin et al., 2007). This mechanism did not
appear likely in the our experimental paradigms, given that we observe a down-regulation of
C1q after paw inflammation and that molecular perturbations applied in this study were
restricted to neurons (above; During et al. 2003)(Fig. 1 & supplementary Fig. 1).
Furthermore, consistent with previous reports (e.g. Lin et al., 2007), we did not observe an
overt spinal microglial activation as assayed by Iba1 immunoreactivity in inflamed mice
(Fig. 7B; supplementary Fig. 5A), in contrast to neuropathic mice (supplementary Fig. 5C).
Furthermore, intrathecal application of C1q to mice with paw inflammation did not induce
microglia proliferation or recruitment (Fig. 7C; supplementary Fig. 5B).
Inspired by recent studies implicating C1q-like proteins, which resemble C1q in structure
and functional motifs, in synaptic morphogenesis during brain development (Chu et al.,
2010; Fourgeaud and Boulanger, 2010), we investigated whether C1q can modulate synaptic
contacts on mature excitatory neurons of the spinal cord. Dissociated neonatal mouse spinal
cord cultures matured over 4 weeks in vitro were infected with an rAAV-CaMKII-EGFP
construct enabling visualization of the dendritic trees and synaptic spines in virus-targeted
excitatory neurons. A significant reduction of the density of EGFP-labeled dendritic
synaptic spines was observed upon a single application of C1q, but not vehicle alone, to
mature cultures within 24 h, which was even more pronounced at 96 h (typical examples in
Fig. 7D; a quantitative analysis in Fig. 7E). C1q application did not evoke signs of nuclear
damage or cell death in neurons (data not shown). Spinal expression of rAAVs expressing
shRNAs against C1q-c (validation in neurons via QRT-PCR is shown in Fig. 7F), led to a
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small, but significant, increase in spine number on dendrites of cultured spinal neurons (Fig.
7G).
Similar to the results obtained with spinal cord neurons, expression of CaMBP4 in
hippocampal neurons led to an increase in C1q-c expression, confirming C1q-c as a nuclear
calcium-regulated gene (Fig. 7H). Application of recombinant C1q markedly reduced spine
density on hippocampal neurons (Fig. 7I, quantification in 7J). However, in contrast to
spinal neurons, we did not detect a significant effect of the knockdown of C1q-c via shRNA
on the spine density of hippocampal neurons (Fig. 7J).
We next investigated the role of C1q as a possible modulator of synaptic spine density in
vivo by performing Golgi staining on spinal cords derived from mice 24 h after intraplantar
paw injection of CFA or PBS (Fig. 8A). Because the very superficial dorsal horn neurons
displayed less sensitivity to impregnation, we restricted our analysis to lamina II neurons
and mostly to large pyramidal lamina V neurons. These showed a marked increase in spine
density on primary and secondary dendrites in inflamed mice as compared to control mice
(examples in Fig. 8B, higher magnification in Fig. 8C and quantification in Fig. 8D). Mice
injected spinally with rAAV-C1q-c-shRNA-GFP showed an increase in spine density on
spinal neurons as compared to rAAV-scrambled-shRNA-GFP-injected mice (Fig. 8C, 8F).
In contrast, following intrathecal application of recombinant C1q in inflamed mice, CFA-
associated increase in spine density was significantly reduced (Fig. 8C, 8D). Similarly,
following stereotaxic in vivo injection of C1q in the hippocampus of adult mice, a
significant reduction in spine density in pyramidal neurons of CA1 region was observed
(Fig. 8E).
Finally, nuclear calcium-evoked spinal C1q downregulation was simulated by injection of
rAAV-C1q-c-shRNA-GFP (using rAAV-scrambled-RNA as a control) into the spinal dorsal
horn; whereas basal mechanical sensitivity was largely unaltered upon spinal C1q
knockdown, the extent of inflammatory mechanical hypersensitivity was significantly
increased as compared to mice expressing scrambled control RNA (Fig. 8G and
supplementary Fig. 7A, B). Conversely, when we intrathecally applied recombinant trimeric
C1q, significant attenuation of CFA-induced mechanical and thermal hypersensitivity was
observed (Fig. 8H, I and supplementary Fig. 7C, D; P < 0.05, ANOVA) without any change
in basal thermal and mechanical sensitivity in the absence of inflammation (Supplementary
Fig. 8A–D). Taken together with the morphological data, these experiments provide
evidence for a novel nuclear calcium target gene in the modulation of inflammation-
associated pain hypersensitivity as well as structural plasticity.
Discussion
The interplay between synaptic receptors, cytoplasmic effectors and the nucleus plays a
critical role in linking membrane depolarization to gene transcription. Here we show that
high threshold, persistent nociceptive input leads to calcium entry into the nuclei of spinal
dorsal horn neurons, which exhibit a specific transcriptional response drives structural
remodelling in spinal excitatory neurons and functional changes, leading to chronic
inflammatory hypersensitivity.
We observed that progressively augmenting recruitment of A-delta afferents and C-type
nociceptors as well as stimulating nociceptors with increasing frequencies led to progressive
rise in the amplitude of activity evoked-nuclear calcium signals, suggesting that nuclear
calcium integrates spinal neuron input from persistent activation of nociceptors after injury.
Interestingly, using constant stimulation parameters in naïve or CFA-inflamed mice, we
found no detectable differences in the characteristics of evoked nuclear calcium signals,
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consistent with the concept that nuclear calcium transients are upstream, not downstream, of
activity-induced plasticity. These data are consistent with the observed specific role for
CaMBP4 in markedly attenuating inflammatory hypersensitivity triggered repetitive
activation of nociceptors without affecting basal and acute nociceptive responses evoked by
an acute activation of nociceptors. These findings, taken together with the results of
experiments addressing the temporal profile of the impact of blockade nuclear calcium
signaling on nociceptive hypersensitivity, indicate that a genomic program governed by
nuclear calcium signaling in spinal neurons plays a major role in the induction of long-
lasting nociceptive hypersensitivity following persistent nociceptive activity, but not in its
maintenance.
Nociceptive activity-induced phosphorylation of CREB has been reported in models of
inflammatory and neuropathic pain (Ji and Rupp, 1997). CaMKII activity as well as protein
kinases PKA, PKC and ERK1/2 have been implicated in CREB phosphorylation in spinal
nociceptive neurons (Kawasaki et al., 2004; Wang et al., 2011). We observed that blocking
nuclear calcium signaling in spinal excitatory neurons blocked nociceptive activity-driven
phosphorylation of CREB albeit ERK1/2 were activated normally, indicating that other
synapse-to-nucleus messengers are not sufficient for activating CREB in spinal neurons in
the absence of nuclear calcium signaling. These findings together with the observation that
inflammatory hypersensitivity was attenuated by inhibiting CaMKIV activity indicate that
nuclear calcium-CaMKIV-CREB/CBP signaling is the primary mediator of long-term
nociceptive sensitization.
Whole genome expression array analysis indicated that the transcriptional program
controlled by nuclear calcium in spinal nociceptive neurons spans a wide range of genes,
including key modulators of nociceptive processing and neuronal excitation. These include
several ion-channels such as the beta4 subunits of voltage-dependent calcium channels,
GABA-A channel subunits, the alpha2/delta3 variant of voltage-dependent calcium
channels, which was recently identified as an evolutionarily conserved pain gene regulating
noxious heat pain from drosophila to humans (Neely et al., 2010), amongst others.
Interestingly, spinal nuclear calcium targets spanned several key components of the cellular
machinery involved in promoting AMPA receptor (AMPAR)-mediated transmission at
spinal synapses, e.g., CaMKIIα, GRIP1, which play a key role in potentiating synapses,
unsilencing synapses, and the development of nociceptive hypersensitivity in vivo (Li et al.,
1999; Fang et al., 2004). Several of the spinal nuclear calcium-regulated genes are directly
or indirectly involved in spinal long-term potentiation (LTP) mechanisms (Sandkühler,
2009), consistent with our observation that LTP paradigms yield the highest magnitudes of
nuclear calcium transients in spinal neurons. Nuclear calcium signaling is involved in the
transition from early-LTP to late-LTP in hippocampal pyramidal neurons (Bengston et al.
2010), indicating a scope for nuclear calcium signaling in facilitation and amplification of
peripheral nociceptive information passing through the spinal cord on its way to the brain.
Additional nuclear calcium targets included several key pain-relevant GPCRs, GASP1, a
protein which critically regulates trafficking and lysosomal sorting of GPCRs and thereby
mediates drug tolerance to GPCR ligands (Tappe-Theodor et al., 2007) as well as diverse
chemokines, diverse cathepsins, matrix metalloproteases that have been implicated in
synaptic modulation and neuron-glia communication (Kawasaki et al., 2008, Gao and Ji
2004).
An important advantage of the combined approach of cell-specific molecular perturbations,
genome-wide profiling and detailed bioinformatics analyses employed here was that it
opened possibilities for discovering novel mediators of plasticity governed by nuclear
calcium, which could thereby offer unprecedented insights into mechanisms of persistent
pain. Amongst the novel mediators found in silico, we focused on the complement system,
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which we identified as a prominently modulated pathway in neurons of inflamed mice,
different from its previously reported activation in spinal glia of neuropathic mice (Griffin et
al. 2007). As described in details under results, our findings suggest a differential and
reciprocal modulation of the complement system in microglia and neurons in neuropathic
and inflammatory pain states, respectively, and we report that the novel pain-modulatory
role for C1q in inflammatory states described here is associated with synapse elimination in
spinal neurons in response to afferent activity, rather than microglial modulation, underlies.
Because modulation of C1q expression by CaMBP4 as well as shRNAs was restricted to
spinal excitatory neurons, which thereupon showed reciprocal changes in spine density, we
deduce that spinal excitatory neuronal circuits constitute both, the locus of C1q regulation as
well as its action, either in an autocrine or paracrine manner. Interestingly, our analyses on
hippocampal neurons indicate that C1q is a common target of nuclear calcium signaling
across neuronal types, and taken together with data on the role of C1q-like proteins in
developmental synapse pruning in the brain (Chu et al., 2010; Fourgeaud and Boulanger,
2010), appears to function as global regulator of not only developmental spine
morphogenesis, but also activity-dependent remodelling. Indeed, by bidirectionally altering
C1q expression in spinal neurons and combining this with morphometric and behavioral
analyses, we observed a most intriguing and close link between nociceptive activity, C1q
expression levels, density of synaptic spines on spinal neurons in vivo and the magnitude of
inflammatory hypersensitivity. These findings suggest that inflammatory pain involves a
concerted and tightly-regulated unfolding of processes underlying structural remodelling and
functional plasticity and further, they indicate that nuclear calcium signaling plays a key role
in these mechanisms.
In summary, this study places nuclear calcium as a key synapse-to-nucleus messenger
system in spinal excitatory neurons. Moreover, it provides evidence that a nuclear calcium-
driven genomic program shapes activity-dependent functional plasticity as well as structural
remodelling in spinal circuits, thereby amplifying nociceptive sensitivity.
Methods
Virus production and in vivo injection
A recombinant adeno-associated virus (rAAV) vector with a AAV1/AAV2 chimeric
backbone containing a 1.3 kbp fragment of the mouse CaMKIIα promoter was used to
express diverse proteins. Viral particles were produced, purified and injected
intrahippocampally as described previously (Zhang et al. 2009, Mauceri et al. 2011). Spinal
cord injections of virions (2–5 × 109 particles/ml, 500 nl of a 2:1 mixture with 20%
Mannitol) in C57BL/6J adult mice was performed as as described previously (Tappe-
Theodor et al., 2007) at least 3 weeks after surgery prior to behavioral, morphological or
imaging experiments. Please see supplementary methods for details.
Transgenic indicator mice
Mice expressing enhanced green fluorescent protein (EGFP) under the control of the
promoter of the glycine transporter 2 (GlyT2) gene were used for identifying glycinergic
neurons (a generous gift from H.U. Zeilhofer, Univ. Zürich). Mice expressing EGFP under
control of GAD 67 were used for identifying GABAergic neurons (a generous gift from H.
Monyer, Univ. Heidelberg).
Calcium imaging
Lumbar spinal slices with attached dorsal roots were derived from virally-injected mice as
described in details previously (Luo et al., 2008). Dorsal roots were stimulated with 1s trains
(1–100 Hz) of 0.2–3.0 mA square electrical pulses lasting 0.2 ms and Ca2+ responses
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elicited were imaged as described in details previously (Bengston et al. 2010). See
supplementary methods for further details.
Behavioral testing of nociception and pathological nociceptive sensitivity
All animal use procedures were in accordance with ethical guidelines imposed by the local
governing body (Regierungspräsidium Karlsruhe, Germany) and involved mice aged 8–16
weeks and matched for gender and age. Inflammation of the paw or knees (arthritis) was
induced by subcutaneous plantar injection of 20 μl Complete Freund’s Adjuvant (CFA,
Sigma) or 4% Kaolin (Sigma, K7375) with 2% Carrageenan Lambda (Sigma, C-3889) under
isoflurane anesthesia subcutaneously as described previously (Gangadharan et al. 2011). The
Spared nerve injury (SNI) model of neuropathic pain was employed ligating and severing
common peroneal and tibial branches of the left sciatic nerve. Behavioral testing was carried
out in habituated mice by an observer blinded to the identity of the groups. Mechanical
sensitivity was determined upon paw withdrawal to either application of graded force via a
dynamic aesthesiometer (UgoBaile Inc.) or to manual application of graded von Frey hairs
(0.008–4 g) to the plantar surface (Gangadharan et al. 2011). To determine thermal
sensitivity, paw withdrawal latency to a ramp of infrared heat was measured using a plantar
test apparatus (Ugo Basile Inc.). Formalin (1%, 20 μl) or Capsaicin (0.03%, 20 μl) was
injected into the plantar surface of the hindpaw and the duration of nocifensive behaviors
(lifting, licking, or flinching) was measured over 60 min or 5 min, respectively, post-
injection (Gangadharan et al. 2011). Additional details are given in Supplementary
materials.
Antibodies used for Western blotting or immunohistochemistry
The following antibodies were used in dilutions in 5% normal horse serum in PBS for
immunohistohemistry: monoclonal rabbit anti-pCREB und anti-pERK (Cell Signaling)
1:100, monoclonal mouse anti-NeuN: 1:500 (Millipore), monoclonal rabbit anti-GFAP
1:500 (DAKO), polyclonal goat anti-Iba-1: 1:150 (Abcam) and a rabbit Anti-Flag-M2 AB
1:1000 (Sigma), appropriate FITC-conjugated secondary antibodies, anti-Fos antibody
(Rabbit anti-c-Fos Ab-5 1:20000, Merck) followed by biotinylated secondary anti-rabbit
antibody (1:200). Rabbit anti- P-CREB, anti-P-ERK1/2, anti-CREB and anti-ERK1/2 (all
from Cell Signaling Inc.) antibodies were used for Western blotting at 1:1000 in 5% BSA in
TBST overnight followed by anti-rabbit HRP-conjugated antibody (1:2000). See
supplementary methods for further details.
Neuronal cultures and analysis of spine density
Hippocampal neurons from newborn C57BL/6J mice were cultured and was transfected with
a plasmid encoding hrGFP on DIV8 using Lipofectamine 2000 as described (Mauceri et al.
2011). Spinal cord cultures derived from mouse embryos at embryonic day E16 were
infected with AAV-CaMKIIα-EGFP virions at P7, fixed 4 weeks later and examined with a
laser-scanning confocal microscope (Leica SP2 AOBS) using a 100x objective (Leica). To
analyse dendritic spines in vivo, Golgi–Cox staining was performed using an FD Rapid
GolgiStain Kit (FD Neurotechnologies, Ellicott, MD) as described in details in Mauceri et
al., 2011. See details under supplementary methods.
Quantitative RT-PCR
Quantitative RT-PCR (QRT-PCR) was performed using TaqMan Universal PCR Master
Mix with a sequence detection system model 7300 Real Time PCR System (Applied
Biosystems, Foster City, California, USA) with the following FAM dye-labeled TaqMan
MGB probes. See supplementary methods for further details.
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Statistics
All data are expressed as mean ± standard error of the mean (S.E.M.). In behavioral,
morphological and RT-PCR analysis, two-tailed unpaired student’s t-test or one-way
ANOVA with post-hoc Dunnett’s or Fisher’s tests were used. t-tests with Benjamini-
Hochberg correction for multiple comparisons Changes with p < 0.05 were considered to be
significant.
Gene profiling and bioinformatics analysis
cDNA samples for gene profiling analysis were prepared as described in Zhang et al. 2009
and analyzed as described under supplementary methods in detail. While representing genes
regulated by CFA inflammation over the naïve state in mCherry-injected mice (i.e. controls),
a cut-off of 1.4 was applied for upregulated genes and a cut-off of 0.7 was applied for
downregulated genes. In order to assess how CFA-induced up- or downregulation of genes
was affected by interfering with nuclear calcium signaling in spinal neurons, fold regulation
(i.e. CFA over naïve) was compared between mCherry-injected mice and CaMBP4-injected
mice. The percent change in down- or up-regulation was calculated for all genes for which
CaMBP4 fold-changes were <= 0.70 or >= 1.40 using the following formula: 100% *
[(CaMBP4 − 1) − (mCherry − 1)]/(mCherry − 1). For genes for which CaMBP4 fold-
changes were > 0.70 or < 1.40, the percent change in down- or up-regulation was set at
100%. Gene Ontology (GO) analysis was performed on regulated genes using a Perl
program ‘map2slim’ from ‘go-perl’ (http://search.cpan.org/~cmungall/go-perl/go-perl.pod)
as described in details under supplementary methods. Network analysis and visualization
and pathway analysis were performed using MetaCore (www.genego.com; Ekins et al.,
2007) as described in details under supplementary methods.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Nociceptive-like signals induce nuclear calcium transients in spinal cord
neurons
• Spinal nuclear calcium regulates a distinct genomic program in pain states
• C1q, a novel target of nuclear calcium signaling, induces synaptic spine
remodeling
• Blockade of nuclear calcium signaling in spinal cord inhibits long-term
inflammatory pain
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Fig. 1.
Viral vector mediated gene transfer to the lumbar spinal dorsal horn in vivo. (A) Schematic
representation of two rAAVs: a nuclearly-targeted mCherry control (mCherry.NLS) and
nuclear-localized, mCherry-tagged CaMBP4 (CaMBP4). (B) Co-expression of CaMBP4
with neuronal (NeuN), astrocytic (GFAP), and microglial (Iba-1) marker proteins in the
spinal dorsal horn (scale bar = 50 μm). (C) Quantification of mCherry.NLS and CaMBP4
colocalization with NeuN in the spinal cord dorsal horn (L3–L5). (D, E) Typical expression
patterns of CaMBP4 and EGFP in glycinergic (GlyT2-EGFP) or GABAergic (GAD67-
EGFP) indicator mice (scale bar = 100 μm in D) and quantification of colocalization (E). (F,
G) rAAV expressing genetically-encoded nuclear calcium indicator, GCaMP2.NLS and
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nuclear calcium signals observed in dorsal horn neurons prior to (pre) and upon electrical
stimulation of the ipsilateral dorsal root (post). (H) Typical ΔF/F trace of nuclear calcium
transients evoked by 1 s, 100 Hz stimulation of the dorsal root. (I, J) Summary of data
showing the relative amplitudes of nuclear calcium signals evoked by 1 s dorsal root
stimulation of varying amplitudes at 20 Hz (n = up to 24 slices)(I) or 100 Hz (n = up to 18
slices)(J). (K) Summary data showing the relative amplitudes of nuclear calcium signals
evoked by 1 s, 0.8 mA stimulus trains of varying frequency (n = up to 10 slices).
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Fig. 2.
Inhibitors of nuclear calcium signaling in the spinal dorsal horn disrupt the development of
inflammatory hyperalgesia, but have no influence on basal pain sensitivity. (A, B) Animals
expressing mCherry (control, black symbols), functional CaMBP4 (red symbols), or an
inactive mutant of CaMBP4 (CaMBP4mu, green symbols) were subjected to punctuate
mechanical pressure stimuli (dynamic aesthesiometer in panel A) or radiant heat (plantar test
with heat ramp in panel B). (C, D) Drop in paw withdrawal latency (C) or mechanical
response thresholds (D) over time following CFA-induced unilateral hind paw inflammation
on day 0. (* P < 0.05 relative to baseline; †P < 0.05 relative to mCherry; One-way ANOVA,
post-hoc Dunnett’s test). (E) Integrals of mechanical stimulus-response frequency curves for
von Frey hair forces ranging from 0.07 to 2 g following unilateral hindpaw CFA injection (†
P < 0.05 relative to mCherry). (F) Anti-Flag immunohistochemistry showing localization of
dominant-negative CaMKIV (CaMKIVK75E) in the spinal dorsal horn (scale = 100 μm,
higher magnification in panel at the right, scale = 50 μm). (G, H) CFA-induced mechanical
hypersensitivity in control mice and mice expressing CaMKIVK75E expressed as % change
over baseline (G) or as integral of the entire von Frey stimulus intensity-response frequency
curve (H) (* P < 0.05 relative to baseline; † P < 0.05 relative to mCherry; one-way ANOVA
followed by Dunnett’s test). (I) CFA-induced thermal hypersensitivity in control mice and
mice expressing CaMKIVK75E (one-way ANOVA). In all panels, n = 8–10 mice/treatment
group.
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Fig. 3.
Contribution of nuclear calcium signaling in spinal dorsal horn neurons to phosphorylation
of CREB (pCREB; panels A and B) and ERK1 as well as ERK2 (pERK1/2; panels C and D)
in the spinal cord and temporal analysis of the course of gene following CFA-induced
unilateral hindpaw inflammation. In panels A and C, identical sections are represented in
both fluorescence channels per group. (A, B) Typical examples of immunoreactivity for
pCREB (A) or Western blotting of pCREB and its densitometric quantification upon
normalizing total CREB levels (B) in the spinal dorsal horn at 24 h after CFA injection as
compared to basal state in mice spinally expressing mCherry or CaMBP4. (C, D) Typical
examples of immunoreactivity for phosphorylated ERK1 and ERK2 (pERK1/2) in the spinal
dorsal horn (C) or Western blotting of pERK1 and pERK2 and densitometric quantification
upon normalizing total ERK1 or ERK2 levels (D) at 24 h after CFA injection over basal
values in mice spinally expressing mCherry or CaMBP4 (* indicates P < 0.05 as compared
to basal levels). Scale bars = 100 μm. In the above panels, n = 4–5 mice/treatment group. (E,
F) Quantitative RT-PCR analysis of time course of upregulation of typical immediate-early
genes (E) and gene encoding some typical effectors of nociceptive hypersensitivity (F) in
spinal dorsal horn of wild-type mice following CFA-induced paw inflammation. n = at least
3 each. In all panels, ANOVA was performed followed by post-hoc Fisher’s test. *
represents P < 0.05 as compared to basal levels (0 h) and † indicates P < 0.05 as compared
to the mCherry group
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Fig. 4.
Effects of CaMBP4-induced disruption of spinal nuclear calcium signaling on behavioral
manifestations of early nociceptive hypersensitivity (capsaicin test) and persistent
inflammatory pain (knee arthritis model). Mice represented in panels A–D received
AAV1/2-mediated spinal delivery of CaMBP4 (red symbols) or mCherry (black symbols) 4
weeks prior to being tested in the capsaicin or arthritis models. Mice represented in panels E
and F received viral-mediated spinal delivery of CaMBP4 or mCherry at 36 h after induction
of knee arthritis. (A, B) The cumulative durations of acute nocifensive behaviors evoked by
intraplantar injection of capsaicin (A) or formalin (B) are shown (P > 0.05; Student’s t-test).
(C, D) Mechanical hypersensitivity following knee arthritis is represented as a change in
mechanical threshold over baseline in % in panel C and as an integral of the entire von Frey
stimulus intensity-response frequency curve over time after knee arthritis in panel D. In all
of the above panels, n = 8–10 mice/treatment group. (E, F) Effects of spinal expression of
mCherry (n= 8) or CaMBP4 (n= 8) using rAAVs injected two days after induction of knee
arthritis. Mechanical hypersensitivity is represented as an integral of the entire von Frey
stimulus intensity-response frequency curve over time after knee arthritis in panel E.
Mechanical sensitivity of the same cohort of mice to a low-intensity von Frey stimulus of
0.07g is shown in panel F. In panels C–F, * indicates P < 0.05 as compared to baseline
values and † indicates P < 0.05 as compared to the mCherry group; ANOVA was performed
followed by post-hoc Dunnett’s test.
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Fig. 5.
Representation of gene profiling data derived from spinal dorsal horns of CaMBP4-
expressing mice and mCherry-expressing mice in the basal state or 24 h after CFA-mediated
bilateral paw inflammation (n = 4 per group). (A–D) Representation of genes upregulated
with a cut-off of 1.4 (A) or downregulated with a cut-off of 0.7 (C) in CFA-inflamed mice
over basal state in mCherry mice. Changes in CFA-induced upregulation (B) or down-
regulation (D) of individual genes by spinal expression of CaMBP4 are represented,
segregated according to magnitude of modulation (color key on the extreme right; white
fields represent CFA-regulated genes that are not affected by CaMBP4 expression). Each
field in panels A & C represents 1 gene and the same gene is represented in corresponding
fields in the panels B and D, respectively. See methods section for detailed description of the
method of calculating % modulation of CFA-induced gene regulation by CaMBP4. (E)
Validation of genes regulated in profiling experiments via quantitative reverse-transcriptase
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PCR on cDNA derived from spinal dorsal horns of mice in the basal state and at 24 h after
CFA-induced paw inflammation. (F) Attenuation of CFA-induced upregulation of Ptgs2
gene encoding Cox-2 in the spinal dorsal horn of mice expressing an shRNA against Ptgs2
in the spinal cord (Student’s t-test). (G, H) Comparison of CFA-induced mechanical
hypersensitivity (G) or thermal hyperalgesia (H) in mice spinally expressing shRNA against
Ptgs2 or control RNA (H); n = 8–10 mice/treatment group.* indicates P < 0.05 as compared
to baseline values; ANOVA followed by post-hoc Dunnett’s test.
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Fig. 6.
Analysis of the regulation of nuclear calcium-gene targets in models of peripheral
inflammation (CFA) or neuropathy (spared nerve injury, SNI) and phenotypic
characterisation of the influence of blockade of spinal nuclear calcium signaling on
neuropathic pain. (A, B) Quantitative RT-PCR analysis of spinal expression of some
neuropathic pain-associated genes at 24h post CFA and of some inflammatory pain-
associated genes at 7 days after SNI (B)(n = 3 mice per condition in A & B). (C, D)
Mechanical hypersensitivity following SNI is represented as a change in mechanical
threshold over baseline in % in panel C and as an integral of the entire von Frey stimulus
intensity-response frequency curve for von Frey hair forces ranging from 0.07 to 1 g over
time after SNI in panel D; (n = 7–8) (* P < 0.05 relative to baseline, n.s.: non-significant, † P
< 0.05 relative to mCherry).
Simonetti et al. Page 25
Neuron. Author manuscript; available in PMC 2014 January 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 7.
Analysis of C1q, a novel nuclear calcium target, its relation to spinal microglia and its role
in dendritic spine remodelling in spinal and hippocampal neurons in vitro. (A) Quantitative
RT-PCR analysis of spinal expression of C1q-c at 24 h after hindpaw injection of CFA and
at 6 days after SNI over basal state in CaMBP4- or or mCherry-mice (n = 4 each). (B, C)
Spinal microglia identified via Iba1-immunoreactivity in the spinal dorsal horns of control
mice, inflamed mice and inflamed mice treated with intrathecal C1q (100 ng) for 48 h; n = 3
mice/group. (D, E) Typical examples (D) and quantitative summary (E) of morphometric
analysis of EGFP-labeled synaptic spines on cultured, mature spinal cord neurons following
treatment with C1q (100 ng) or vehicle over 24h–96h or following treatment with shRNA
against C1q expression or control RNA (Scale bar = 50 μm in the upper panels, 5 μm in the
lower panels; at least n = 3 different culture preparations). (F) QRT-PCR analysis of
expression of the C1qc subunit of the trimeric C1q complex validating shRNA-mediated
knockdown. (G) Typical examples of spinal neuronal morphology and spine density in
spinal neurons with AAV-mediated downregulation of C1q expression as compared to
controls. (H) QRT-PCR analysis of C1q-c expression in uninfected hippocampal neurons
and in hippocampal neurons infected with rAAVs expressing the indicated proteins (n=4). *
indicates P < 0.05 as compared to uninfected. (I, J) Typical examples (I) and quantitative
summary (J) of morphometric analysis of EGFP-labeled synaptic spines on hippocampal
neurons at 10 days or 16 days in vitro (DIV) (Scale bar = 20 μm in the upper panels and 5
μm in the lower ones) upon treatment with C1q (100 ng) or vehicle over 24h–96h or
following viral expression of C1q-c shRNA or scrambled RNA. * P < 0.05 as compared to
corresponding control. n= >600 spines counted, 12 neurons per condition, 3 independent
culture preparations.
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Fig. 8.
Spine remodelling in spine dorsal horn neurons following peripheral inflammation in vivo
via the the novel nuclear calcium target, C1q, and its role in inflammatory pain
hypersenstivity. (A) Typical example of Golgi staining on spinal dorsal horn slices with
neurons labeled scross lamina II–V. Scale bar = 200 μm. (B) Typical examples of labelled
neurons in mice injected intraplantar with PBS or CFA (24 h post-injection). Scale bar = 20
μm. (C) High magnification views of microscopic images of labelled dendrites with
synaptic spines in mice with intraplantar injection of PBS or CFA (24 h) and treated
intrathecally with vehicle or C1q (100 ng). Right hand panels represent images from mice
with rAAV-mediated expression of C1q shRNA or scrambled RNA in spinal dorsal horn
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neurons in vivo. Scale bar = 10 μm (D, E) Quantitative summary of synaptic spine density
in spinal dorsal horn neurons (D) or in hippocampal neurons (E) in vivo following
intrathecal injection (D) or direct intrahippocampal injection (E) of C1q (100 ng) (3–4
animals per condition, 20–30 neurons, 500–700 spines counted analysed spinal neurons; 2
animals per condition, 14 neurons, more than 600 spines analysed for hippocampal neurons).
(F) Quantitative summary of synaptic spine density in spinal dorsal horn neurons in mice
with rAAV-mediated expression of C1q-c shRNA or scrambled RNA (2 animals, 20
neurons per condition, 300–500 spines counted). (G, H) CFA-induced mechanical
hypersensitivity in mice injected with rAAV-C1qc-shRNA or rAAV-scrambled RNA at 24 h
(G) (n = 3–4/group) or in mice following intrathecal administration of recombinant C1q
(100 ng) or vehicle 3-times over 24h period post-CFA (H) (n = 6 each group). In panels D,
G, H & I, * indicates P < 0.05 as compared to baseline values within the same group and †
indicates P < 0.05 as compared to the corresponding control group; in panels E & F, * P <
0.05 between the two groups ANOVA followed by post-hoc Dunnett’s test.; In all panels,
ANOVA followed by post-hoc Dunnett’s test.
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